Literature DB >> 26683775

Molecular mechanisms of microRNAs in regulating epithelial-mesenchymal transitions in human cancers.

Jinlong Tang1, Yuan Li2, Jingyu Wang3, Zhineng Wen4, Maode Lai5, Honghe Zhang6.   

Abstract

The epithelial-mesenchymal transition (EMT) provides a strong driving force in the progression of various human cancers and the development of chemoresistance. Recently, numbers of studies have demonstrated that microRNAs (miRNAs), by post-transcriptionally silencing EMT-related molecules, can promote or inhibit the EMT process and play pivotal roles in effectively manipulating the occurrence, development, invasion, and metastasis of cancers. MiRNAs can also control the EMT or be controlled by genetic modification and mutual regulation, especially negative feedback. Therefore, miRNAs can be viewed as either oncogenes or tumor suppressor genes to facilitate or retard the EMT, resulting in far-reaching impact on tumor metastasis and effective diagnosis, treatment, and prognosis.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; EMT; miRNAs

Mesh:

Substances:

Year:  2015        PMID: 26683775     DOI: 10.1016/j.canlet.2015.11.043

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  28 in total

1.  Potential biomarkers for radiosensitivity in head and neck cancers.

Authors:  Sherly Pardo-Reoyo; J L Roig-Lopez; Eddy S Yang
Journal:  Ann Transl Med       Date:  2016-12

2.  Cross-talk between microRNA-let7c and transforming growth factor-β2 during epithelial-to-mesenchymal transition of retinal pigment epithelial cells.

Authors:  Qu-Zhen Deji; Feng Yan; Wang-Dui Zhaba; Ya-Jun Liu; Jie Yin; Zhen-Ping Huang
Journal:  Int J Ophthalmol       Date:  2020-05-18       Impact factor: 1.779

Review 3.  Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.

Authors:  Fu Peng; Liang Xiong; Hailin Tang; Cheng Peng; Jianping Chen
Journal:  Tumour Biol       Date:  2016-09-19

4.  Knockdown of microRNA-214-3p Promotes Tumor Growth and Epithelial-Mesenchymal Transition in Prostate Cancer.

Authors:  Patrice Cagle; Nikia Smith; Timothy O Adekoya; Yahui Li; Susy Kim; Leslimar Rios-Colon; Gagan Deep; Suryakant Niture; Christopher Albanese; Simeng Suy; Sean P Collins; Deepak Kumar
Journal:  Cancers (Basel)       Date:  2021-11-23       Impact factor: 6.639

5.  PEP06 polypeptide 30 exerts antitumour effect in colorectal carcinoma via inhibiting epithelial-mesenchymal transition.

Authors:  Siming Yu; Linna Li; Wei Tian; Dan Nie; Wei Mu; Fang Qiu; Yu Liu; Xinghan Liu; Xiaofeng Wang; Zhimin Du; Wen-Feng Chu; Baofeng Yang
Journal:  Br J Pharmacol       Date:  2018-06-15       Impact factor: 8.739

6.  miR-24-3p Suppresses Malignant Behavior of Lacrimal Adenoid Cystic Carcinoma by Targeting PRKCH to Regulate p53/p21 Pathway.

Authors:  Ming-Xue Zhang; Jie Zhang; Hong Zhang; Hua Tang
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

Review 7.  MicroRNA biogenesis and their functions in regulating stem cell potency and differentiation.

Authors:  Shaomian Yao
Journal:  Biol Proced Online       Date:  2016-03-09       Impact factor: 3.244

Review 8.  Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review).

Authors:  Jingyu Wang; Yuan Li; Meiman Ding; Honghe Zhang; Xiaoming Xu; Jinlong Tang
Journal:  Int J Oncol       Date:  2016-12-19       Impact factor: 5.650

Review 9.  Epithelial-mesenchymal transition: potential regulator of ABC transporters in tumor progression.

Authors:  Zong-Sheng Jiang; Yan-Zi Sun; Shao-Ming Wang; Jun-Shan Ruan
Journal:  J Cancer       Date:  2017-07-21       Impact factor: 4.207

10.  Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.

Authors:  Wei Lu; Honghe Zhang; Yuequn Niu; Yongfeng Wu; Wenjie Sun; Hongyi Li; Jianlu Kong; Kefeng Ding; Han-Ming Shen; Han Wu; Dajing Xia; Yihua Wu
Journal:  Mol Cancer       Date:  2017-07-11       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.